Ophthalmology

Top Story

Can the solo practice premium surgeon survive in today’s health care environment?

Can the solo practice premium surgeon survive in today’s health care environment?
Ocular Surgery News U.S. Edition, April 10, 2017
Mitchell A. Jackson, MD

Twenty-four years ago, I was completing my third year of ophthalmology residency and already had plans to open a private practice solo in a somewhat rural location at that time outside of Chicago. Even as far back as 1993, it was rare to go solo, knowing the financial risks involved at that time. Most of my colleagues either went directly into a fellowship program or joined a group or corporate practice.

In 2017, with the changing landscape of health care, with the need for electronic medical records (EMR), data reporting in terms of meaningful use (MU), Physician Quality Reporting System (PQRS) and soon Merit-based Incentive Payment System (MIPS) and Medicare Access and CHIP Reauthorization Act (MACRA), and the financial penalties for not following such, it seems nearly impossible to consider embarking on a solo practice career. For those brave premium surgeons who have established themselves as or are about to become solo practice warriors, here are a few survival guide tips that have helped me as I approach my 25th year in practice.

Point/Counter

Will MIGS replace drops as first-line treatment?

Ocular Surgery News U.S. Edition, April 10, 2017
Point Microinvasive glaucoma surgery has the potential to replace drops as first-line therapy, not in all situations but in certain ones. When a newly diagnosed patient…
By the Numbers

Address partner compensation issues early and often

Ocular Surgery News U.S. Edition, April 10, 2017
John B. Pinto
“When somebody says it’s not about the money, it’s about the money.” – H.L. Mencken
Complications Consult

Technique offers individualized approach for vision correction

Ocular Surgery News U.S. Edition, April 10, 2017
Arun C. Gulani, MD
In this new era of high patient expectations and technological advancements, we are on a quest to achieve “super vision.” In this view…
Lindstrom's Perspective

MIGS devices greatly expand treatment armamentarium

Ocular Surgery News U.S. Edition, April 10, 2017
Richard L. Lindstrom, MD
The recent FDA approvals of the Glaukos iStent, Alcon CyPass and Allergan Xen surgical devices for the treatment of glaucoma have significantly expanded the options for…
More News Headlines »
Clinical Science

Microscope-Integrated OCT Feasibility and Utility With the EnFocus System in the DISCOVER Study

Ophthalmic Surgery, Lasers and Imaging Retina, March 2017, Volume 48 Issue 3
To evaluate the feasibility and utility of a novel microscope-integrated intraoperative optical coherence tomography…
More »
CME

Treating Advanced Dry Age-related Macular Degeneration and Geographic Atrophy: Here and Now

This activity is supported by an educational grant from Allergan, Inc.

Dry eye disease (DED) is a condition of the ocular surface in which multiple factors are responsible for the…
More »
Featured
World Retina Congress

World Retina Congress

Video
Meeting News

VIDEO: HR experts tackle hot topics from immigration to Generation Z

March 1, 2017
More »
Advertisement
Advertisement